Insight Molecular Diagnostics Inc. — Director's Dealing 2025

Nov 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Insight Molecular Diagnostics Inc. (IMDX)
CIK: 0001642380
Period of Report: 2025-10-31

Reporting Person: James Andrea S. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-10-31	Common Stock	M	50000	—	Acquired	201231	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-10-31	Restricted Stock Units	$	D	50000	Acquired		Common Stock (50000)	Direct

Footnotes

F1: Represents an award of performance-based restricted stock units ("RSUs") issued pursuant to the Company's 2018 Equity Incentive Plan. Each RSU represents the right to receive, at settlement, one share of Common Stock.

F2: The RSUs vested on the last day of the month upon satisfaction of the "Baby Shelf" performance condition described in the Reporting Person's Employment Agreement, which required that the Company's public float reach at least $75 million such that the Company would no longer be subject to the SEC's "baby shelf" limitations on Form S-3 eligibility. The satisfaction of this condition resulted in the vesting of 50% of the RSUs granted to the Reporting Person, subject to the Reporting Person's continued service.